Axon Enterprise
AXON
#541
Rank
NZ$75.50 B
Marketcap
NZ$956.79
Share price
0.39%
Change (1 day)
-13.06%
Change (1 year)

Earnings for Axon Enterprise (AXON)

Earnings in 2025 (TTM): NZ$0.41 Billion

According to Axon Enterprise 's latest financial reports the company's current earnings are NZ$2.55 Billion. In 2024 the company made an earning of NZ$0.67 Billion, an increase over its 2023 earnings that were of NZ$0.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Axon Enterprise from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.41 B-37.76%
2024 NZ$0.67 B147.92%
2023 NZ$0.27 B68.08%
2022 NZ$0.16 B-155.47%
2021 -NZ$0.3 Billion1088.15%
2020 -NZ$24.48 Million121.3%
2019 -NZ$11.07 Million-125.74%
2018 NZ$42.96 M90.75%
2017 NZ$22.52 M-59.11%
2016 NZ$55.09 M-9.86%
2015 NZ$61.12 M8.71%
2014 NZ$56.22 M10.67%
2013 NZ$50.8 M43.35%
2012 NZ$35.44 M-402.97%
2011 -NZ$11.7 Million33.15%
2010 -NZ$8.79 Million6315.17%
2009 -NZ$0.14 Million-100.45%
2008 NZ$30.21 M-14.25%
2007 NZ$35.24 M-474.06%
2006 -NZ$9.43 Million-449.46%
2005 NZ$2.69 M-94.95%
2004 NZ$53.4 M307.28%
2003 NZ$13.11 M1999.86%
2002 NZ$0.62 M-63.88%
2001 NZ$1.72 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
XBiotech
XBIT
-NZ$49.73 Million-112.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-NZ$0.14 Billion-133.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-NZ$0.19 Billion-146.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$1.51 B 268.45%๐Ÿ‡บ๐Ÿ‡ธ USA